07/14/2014 - 12:39pm

Lindt & Sprüngli Group announced on Monday that it has reached an agreement to purchase Russell Stover Candies. The Russel Stover and Whitman's brands will complement Lindt & Sprüngli's existing portfolio of premium chocolates, making it the No. 3 North American chocolate manufacturer, the company said.

07/14/2014 - 12:31pm

Walgreens on Monday expanded vaccine availability at all of its more than 800 locations across Florida as new state legislation takes effect to help bring greater patient access to vaccines.

07/14/2014 - 11:45am

Sandoz on Monday announced the introduction of tobramycin inhalation solution, USP into the U.S. market. The drug is an authorized generic version of Tobi from Novartis.

07/14/2014 - 11:30am

Pure Encapsulations recently launched PureBiOme, a line of probiotics using proprietary PureBiOme freeze-drying technology, which enables probiotics to maintain potency when combined with active ingredients for the first time.

07/14/2014 - 11:21am

The Warrell Corp., a family owned manufacturer of candies and snacks, announced the introduction of Flipsticks Taffy bars.

07/14/2014 - 11:13am

At the close of the Affordable Care Act’s first open enrollment period, an estimated 9.5 million fewer U.S. adults were uninsured, according to a new Commonwealth Fund survey released last week.

07/14/2014 - 11:02am

Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.

07/14/2014 - 10:56am

 According to blogger Tom Wilson, co-founder and president of The CareGiver Partnership and former Kimberly-Clark executive, Procter & Gamble may be readying to re-enter the incontinence market as soon as this summer.

07/14/2014 - 10:51am

Teva Pharmaceuticals on Monday announced that the Food and Drug Administration has accepted the company's new drug application for albuterol multi-dose dry-powder inhaler, a breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease.